ClinicalTrials.govpublic full text
Evaluating Anti-Obesity Medications 6 Months After Metabolic Surgery
obesity, weight loss, metabolic surgery, bmi, glp-1 receptor agonist, efsubaglutide alfa, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 800370
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.